|
|
(68 intermediate revisions not shown) |
Line 10: |
Line 10: |
| <ul class="menu"> | | <ul class="menu"> |
| <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union"> Home </a> </li> | | <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union"> Home </a> </li> |
- | <li class="menu"> Project | + | <li class="menu-project"> Project |
| <ul class="menu"> | | <ul class="menu"> |
- | <li class="menu"> <a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/TdT_project">De Novo Synthesis </a></li> | + | <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/TdT_project">De Novo Synthesis </a></li> |
- | <li class="menu"> <a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/Telomere_project">Programmable Lifespan</a> </li> | + | <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Telomere_project">Programmable Lifespan Timer</a> </li> |
- | <li class="menu"> <a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/Biohack_project">Biohacker Kit </a></li> | + | <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Biohack_project">Biohacker Kit </a></li> |
- | <li class="menu"> <a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/Hardware">OpenSource Hardware </a> </li> | + | <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Hardware">OpenSource Hardware </a> </li> |
- | <li class="menu"> <a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/Parts">BioBrick Parts </a></li>
| + | <!--<li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Modeling">Modeling </a> </li>--> |
- | <li class="menu"> <a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/Modeling">Modeling </a> </li> | + | <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Parts">BioBrick Parts </a></li> |
| </ul> | | </ul> |
| </li> | | </li> |
- | <li class="menu"> <a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/Safety">Safety</a> </li> | + | <li class="menu-safety"> Social |
- | <li class="menu"><a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/Outreach"> Outreach </a></li>
| + | <ul class="menu"> |
- | <li class="menu"> Notebook | + | <li class="menu"><a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Safety">Safety</a> </li> |
| + | <li class="menu"><a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Ethics">Ethics</a> </li> |
| + | <li class="menu"><a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Outreach">Outreach </a></li> |
| + | </ul> |
| + | </li> |
| + | <li class="menu-notebook"> Notebook |
| <ul class="menu"> | | <ul class="menu"> |
| <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Protocols">Commonly Used Protocols </li> | | <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Protocols">Commonly Used Protocols </li> |
Line 28: |
Line 33: |
| </ul> | | </ul> |
| </li> | | </li> |
- | <li class="menu"> Team | + | <li class="menu-team"> Team |
| <ul class="menu"> | | <ul class="menu"> |
- | <li class="menu"> <a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/biofanfic">Members </a> </li> | + | <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/biofanfic">Members </a> </li> |
- | <li class="menu"> <a class="menu" href="https://2014.igem.org/wiki/index.php?title=Team:Cooper_Union/Attributions"> Attributions </a> </li> | + | <li class="menu"> <a class="menu" href="https://2014.igem.org/Team:Cooper_Union/Attributions"> Attributions </a> </li> |
| <li class="menu"> <a class="menu" href="https://igem.org/Team.cgi?id=1354"> Official Team Profile </a> </li> | | <li class="menu"> <a class="menu" href="https://igem.org/Team.cgi?id=1354"> Official Team Profile </a> </li> |
| </ul> | | </ul> |
Line 37: |
Line 42: |
| </ul> | | </ul> |
| <a class="menu" href="http://www.igem.org" border="0"> | | <a class="menu" href="http://www.igem.org" border="0"> |
- | <img src="https://static.igem.org/mediawiki/igem.org/f/f2/Igemfooterlogo.png" class="menu-top-logo" /> | + | <img src="https://static.igem.org/mediawiki/igem.org/9/94/Igemlogo_officiallogo.png" class="menu-top-logo" /> |
| </a> | | </a> |
| | | |
| </div> | | </div> |
- | | + | <br> |
| + | <hr> |
| + | <br> |
| + | <div class="text"> |
| <!-----Add content below----> | | <!-----Add content below----> |
| | | |
| | | |
| + | <br><div class="center"> |
| + | <h1>Programmable Lifespan Timer</h1></div> |
| + | <BR><center> |
| + | <img src="https://static.igem.org/mediawiki/2014/e/e7/CU_Telo_ProgrammableLifeSwitchCycle.JPG" width="400" /></center> |
| + | <BR><BR> |
| + | We designed our <b/>Super Safety Strain</b> of <i>S. cerevisiae</i> yeast with industrial scale-up in mind. For engineered strains whose purpose is to synthesize small molecules, such as biofuels and drugs, adequate safeguards are necessary to prevent accidental release and potential production of contaminating small molecules in ecosystems. With that in mind, we had several criteria in mind for our strain: <br><br> |
| + | <ol> |
| + | <li>The strain should be incapable of dividing outside of the production facility</li> |
| + | <li>During production, the strain should be capable of good growth to ensure economic yields of small molecules</li> |
| + | <li>The strain should be incapable of reverting to a wildtype phenotype capable of growth outside of the production facility</li> <li>The phenotype of the Super Safety Strain should be readily identifiable when the safety system is active</li> |
| + | </ol> |
| + | <br> |
| + | To these ends, we have set out to address these challenges by designing our genetic platform around strains that can switch off expression of telomerase, an enzyme that is critical for maintaining the ends of chromosomes (telomeres), along with a battery of additional mutations to shorten or lengthen the lifespan of the cells. |
| + | <BR><center> |
| | | |
| + | <img src="https://static.igem.org/mediawiki/2014/f/f9/CU_Telo_YeastTransformation.JPG" width="400" /> |
| + | <br><BR> |
| + | <img src="https://static.igem.org/mediawiki/2014/5/56/CU_Telo_KnockoutCassette.JPG" width="400" /></center> |
| + | <BR><BR> |
| + | <div class="center"><h2>EST2 Gene Knockout: For Telomerase Inactivation</h2> </div><BR><BR> |
| + | There are several subunits of yeast telomerase that, when deleted, result in a non-functional telomerase. We chose to utilize the well characterized gene EST2 (Ever Shortening Telomeres 2) which codes for the catalytic subunit of yeast telomerase. |
| + | The EST2 gene's main function is as a telomerase reverse transcriptase, and EST2 plays an essential role in telomerase activity. The EST2 gene causes telomere extension, and in addition, EST stands for Even Shorter Telomeres. A mutation, such as a deletion, in the EST2 gene will cause the telomeres to shorten and eventually die off. |
| + | <BR><BR> |
| | | |
| + | <div class="center"><h2>RAD52 Gene Knockout: For Telomere Backup Pathway (ALT) Inactivation</h2></div> |
| + | <br><br> |
| + | However, yeast cells also possess a backup system called ALT (Alternative Lengthening of Telomeres) based on telomere extension via homologous recombination. Several genes are required for this pathway to function, There have been many strain backgrounds generated containing EST2 and RAD52 knockouts, with no strains exhibiting "rescue" from senescence. <br><br> |
| + | The RAD52 gene is a DNA recombinase that allows for cells with shortened telomeres to use homologous recombination to re-extend their telomeres. It is involved in repairing DNA double strand breaks by working with RAD51. In cells with a single EST2 deletion, the RAD52 gene codes for an alternate pathway of recovery. In cells with a double deletion for both EST2 and RAD52, they will reach senescence and not recover. |
| + | <BR><BR> |
| | | |
| | | |
- | RAD52
| + | <div class="center"><h2>MAK31 and VPS75 Gene Knockouts: For Setting Telomere Lengths</h2></div> |
- | The RAD52 gene is a DNA recombinase that allows for cells with shortened telomeres to use homologous recombination to re-extend their telomeres. It is involved in repairing DNA double strand breaks by working with RAD51. In cells with a single EST2 deletion, the RAD52 gene codes for an alternate pathway of recovery. In cells with a double deletion for both EST2 and RAD52, they will reach senescence and not recover.
| + | There are certain genes within S. cerevisiae yeast that have been tested with genome-wide screens for deletion mutants that affect telomere length. Two such genes are MAK31 and VPS75. MAK31, generally categorized as a gene involved in protein modification, specifically with N-acetyltransferase, was found by Askree et al. to lengthen the yeast telomeres by 50-150 base pairs. VPS75, a gene that normally deals with vesicular traffic and vacuolar sorting proteins, was found in the same study to shorten yeast telomeres by 50-150 base pairs.<p>In cells with either a double or triple deletion of MAK31 or VPS75 in conjunction with EST2 and/or RAD52, growth curves should show shifts in when senescence occurs. |
| + | <BR><BR> |
| + | <div class="center"><h2>S. cerevisiae Strains</h2> |
| + | <BR> |
| + | <img src="https://static.igem.org/mediawiki/2014/9/9d/CooperIGEMYeastStrains.png" width="600" /></div> |
| + | <br><BR> |
| + | W303 diploid and BY4741a wildtype strains were generously donated by the Laboratory of Dr. David A. Sinclair, Harvard Medical School. The W303 diploid strain was sporulated and haploid colonies were then selected via replica plating onto selective media to select relevant haploid mutant strains. These strains were also used in our attempts by PCR to generate deletion cassettes. BY4741a strains were used to generate VPs75 and MAK31 deletion mutants by homologous recombination with deletion cassettes that we created using primers containing 5' ends having homology to the gene region and amplifying either a TRP1 or LEU2 cassette from plasmids. |
| + | <br> |
| + | <br> |
| + | <div class="center"><h2>Results</h2> |
| + | <br> |
| + | <table class="data"> |
| + | <caption><b>Daily Cell Density (cells/mL) For EST2, VPS75 and MAK31 Knockouts</b></caption> |
| + | <tr><td></td><td>Day 1</td><td>Day 2</td><td>Day 3</td><td>Day 4</td><td>Day 5</td><td>Day 6</td><td>Day 7</td><td>Day 8</td><td>Day 9</td><td>Day 10</td></tr> |
| + | <tr><td>1296</td><td align="right">61000000</td><td align="right">21400000</td><td align="right">85066666</td><td align="right">58666666</td><td align="right">116866666</td><td align="right">574666667</td><td align="right">78133333</td><td align="right">106866666</td><td align="right">83066666</td><td align="right">86500000</td></tr> |
| + | <tr><td>VPS75</td><td align="right">134500000</td><td align="right">120000000</td><td align="right">113833333</td><td align="right">63800000</td><td align="right">72433333</td><td align="right">111500000</td><td align="right">113700000</td><td align="right">124100000</td><td align="right">115000000</td><td align="right">115400000</td></tr> |
| + | <tr><td>MAK31</td><td align="right">131800000</td><td align="right">118333333</td><td align="right">117833333</td><td align="right">145166666</td><td align="right">118733333</td><td align="right">120066666</td><td align="right">117733333</td><td align="right">125333333</td><td align="right">116400000</td><td align="right">120633333</td></tr> |
| + | </table><br> |
| + | <img src="https://static.igem.org/mediawiki/2014/8/87/CU_Telo_ESTVPSMAK-82514.PNG" width="750" /><br><br> |
| + | <span>The results for VPS75 and MAK31 show our predicted results. After the growth curve decreased on day 3 for VPS75, it increased again on day 4. The VPS75 growth curve leveled off after day 6. The MAK31 growth curve fluctuated a bit, but showed a general trend of decrease and then increase.</span> |
| + | <br><br> |
| | | |
| + | <table class="data"> |
| + | <caption><b>Daily Cell Density (cells/mL) For EST2 and EST2/RAD52 Knockouts</b></caption> |
| + | <tr> <td></td> |
| + | <td>Day 1</td> |
| + | <td>Day 2</td> |
| + | <td>Day 3</td> |
| + | <td>Day 4</td> |
| + | <td>Day 5</td> |
| + | <td>Day 6</td> |
| + | </tr> |
| + | <tr> |
| + | <td>W303A</td> |
| + | <td>137600000</td> |
| + | <td>114500000</td> |
| + | <td>134050000</td> |
| + | <td>129750000</td> |
| + | <td>109050000</td> |
| + | <td>118450000</td> |
| + | </tr> |
| + | <tr> |
| + | <td>ΔEST2 (S21)</td> |
| + | <td>115900000</td> |
| + | <td>16100000</td> |
| + | <td>13800000</td> |
| + | <td>55866666.67</td> |
| + | <td>118600000</td> |
| + | <td>102766666.7</td> |
| + | </tr> |
| + | <tr> |
| + | <td>ΔEST2 (S22)</td> |
| + | <td>112300000</td> |
| + | <td>33433333.33</td> |
| + | <td>15133333.33</td> |
| + | <td>95033333.33</td> |
| + | <td>48900000</td> |
| + | <td>109500000</td> |
| + | </tr> |
| + | <tr> |
| + | <td>ΔRAD52/EST2 </td> |
| + | <td>107500000</td> |
| + | <td>13266666.67</td> |
| + | <td>12366666.67</td> |
| + | <td>10933333.33</td> |
| + | <td>20433333.33</td> |
| + | <td>11233333.33</td> |
| + | </tr> |
| + | </table><BR> |
| + | <img src="https://static.igem.org/mediawiki/2014/1/14/CU_Telo_EST2RAD52EST2_090714.png" width="750" /><br><br> |
| + | |
| + | </div> |
| + | <div class="center"><h2>Future Directions</h2></div> |
| + | Given the forever ongoing nature of research, as well as the limited amount of time, our team was unable to fully complete certain tasks. With the opportunity to continue this project, we hope to proceed by next knocking out the SIR1 Gene or a similar gene with the intention of generating a strain that will be sterile (non-mating). In addition, we hope to control the activation and deletion of ADE2 Reporter Gene and EST2 respectively through the use of Galactose (Galactose Activated Cre Recombinase Switch). |
| + | <BR><BR> |
| + | <b>References</b> |
| + | <ol><li> |
| + | Askree, S.H., Yehuda, T., Smolikov, S., Gurevich, R., Hawk, J., Coker, C., Krauskopf, A., Kupiec, M. and McEachern, M.J. (2004) A genome-wide screen for Saccharomyces cerevisiae deletion mutants that affect telomere length. |
| + | </li> |
| + | <li>Cohen, H., and Sinclair, D.A. (2001) Recombination-mediated lengthening of terminal repeats requires the Sgs1 DNA helicase. PNAS</li> |
| + | <li>Lundblad, V., and Blackburn, E. H. (1993) An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 73:347-360.</li> |
| + | <li>Lundblad, V., and Szostak, J.W. (1989) A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57: 633-643.</li> |
| + | <li>N Nakayama, Y Kaziro, K Arai, and K Matsumoto. (1988)Role of STE genes in the mating factor signaling pathway mediated by GPA1 in Saccharomyces cerevisiae.Mol Cell Biol.8(9): 3777–3783.</li> |
| + | |
| + | <li>Botstein, D., Falcoa, S.C., Stewart, S.C.,Brennan, M., Scherer, S., Stinchcomb,D.T., Struhl, K., and Davis, R.W. (1979) Sterile host yeasts (SHY): A eukaryotic system of biological containment for recombinant DNA experiments</li> |
| + | |
| + | <li>Mackay V, Manney TR. (1974) Mutations affecting sexual conjugation and related processes in Saccharomyces cerevisiae. II. Genetic analysis of nonmating mutants. Genetics. Feb;76(2):273–288</li> |
| + | </ol> |
| | | |
| | | |
Line 59: |
Line 180: |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx --> | | xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx --> |
| </div> | | </div> |
| + | |
| <br> | | <br> |
| <br> | | <br> |
Line 67: |
Line 189: |
| | | |
| | | |
- |
| |
- | <div class="footer">
| |
- |
| |
- | <div class="footer-blurb">
| |
- |
| |
- |
| |
- | <br><br>
| |
| | | |
| | | |
| + | <div class="cu-footer"> |
| + | <div class="bottom-left"> |
| + | <a href="https://2014.igem.org/Team:Cooper_Union" span="The Cooper Union: μToolbox"><img src="https://static.igem.org/mediawiki/2014/b/bd/CU_2014_logo.png" height="150" /></a></div> |
| + | <div class="bottom-center"> |
| + | <a href="https://2014.igem.org/Team:Cooper_Union/Project" class="black" > |
| + | <img src="https://static.igem.org/mediawiki/2014/2/27/CU_2014_LogoP.png" height="100" style="vertical-align: top;" title="Projects" /> |
| + | <span>Projects</span> |
| + | </a> |
| + | <a href="https://2014.igem.org/Team:Cooper_Union/Social" class="red" > |
| + | <img src="https://static.igem.org/mediawiki/2014/b/b2/CU_2014_logoS.png" height="100" style="vertical-align: top;" title="Social" /> |
| + | <span>Social</span> |
| + | </a> |
| + | <a href="https://2014.igem.org/Team:Cooper_Union/Notebook" class="green" > |
| + | <img src="https://static.igem.org/mediawiki/2014/d/da/CU_2014_LogoN.png" height="100" style="vertical-align: top;" title="Notebook" /> |
| + | <span>Notebook</span> |
| + | </a> |
| + | <a href="https://2014.igem.org/Team:Cooper_Union/biofanfic"class="blue"> |
| + | <img src="https://static.igem.org/mediawiki/2014/3/38/CU_2014_LogoT.png" height="100" style="vertical-align: top;" title="Team" /> |
| + | <span>Team</span> |
| + | </a> |
| + | </div> |
| + | <div class="bottom-right"> |
| + | <a href="http://www.cooper.edu" target="_blank" span="The Cooper Union"><img src="https://static.igem.org/mediawiki/2014/9/90/CU_2014_Cooper_union_logo.png" height="150" /></a> |
| + | </div> |
| </div> | | </div> |
| | | |
- |
| |
- |
| |
- | <div class="footer-links">
| |
- |
| |
- | <br><br>
| |
- |
| |
- |
| |
- |
| |
- | </div>
| |
- |
| |
- |
| |
- | <div class="sponsors">
| |
- |
| |
- |
| |
- | <br><br>
| |
- |
| |
- | </div>
| |
- |
| |
- |
| |
- |
| |
- | <br class="clear-left" />
| |
- | </div>
| |
| | | |
| | | |
Programmable Lifespan Timer
We designed our
Super Safety Strain of
S. cerevisiae yeast with industrial scale-up in mind. For engineered strains whose purpose is to synthesize small molecules, such as biofuels and drugs, adequate safeguards are necessary to prevent accidental release and potential production of contaminating small molecules in ecosystems. With that in mind, we had several criteria in mind for our strain:
- The strain should be incapable of dividing outside of the production facility
- During production, the strain should be capable of good growth to ensure economic yields of small molecules
- The strain should be incapable of reverting to a wildtype phenotype capable of growth outside of the production facility
- The phenotype of the Super Safety Strain should be readily identifiable when the safety system is active
To these ends, we have set out to address these challenges by designing our genetic platform around strains that can switch off expression of telomerase, an enzyme that is critical for maintaining the ends of chromosomes (telomeres), along with a battery of additional mutations to shorten or lengthen the lifespan of the cells.
EST2 Gene Knockout: For Telomerase Inactivation
There are several subunits of yeast telomerase that, when deleted, result in a non-functional telomerase. We chose to utilize the well characterized gene EST2 (Ever Shortening Telomeres 2) which codes for the catalytic subunit of yeast telomerase.
The EST2 gene's main function is as a telomerase reverse transcriptase, and EST2 plays an essential role in telomerase activity. The EST2 gene causes telomere extension, and in addition, EST stands for Even Shorter Telomeres. A mutation, such as a deletion, in the EST2 gene will cause the telomeres to shorten and eventually die off.
RAD52 Gene Knockout: For Telomere Backup Pathway (ALT) Inactivation
However, yeast cells also possess a backup system called ALT (Alternative Lengthening of Telomeres) based on telomere extension via homologous recombination. Several genes are required for this pathway to function, There have been many strain backgrounds generated containing EST2 and RAD52 knockouts, with no strains exhibiting "rescue" from senescence.
The RAD52 gene is a DNA recombinase that allows for cells with shortened telomeres to use homologous recombination to re-extend their telomeres. It is involved in repairing DNA double strand breaks by working with RAD51. In cells with a single EST2 deletion, the RAD52 gene codes for an alternate pathway of recovery. In cells with a double deletion for both EST2 and RAD52, they will reach senescence and not recover.
MAK31 and VPS75 Gene Knockouts: For Setting Telomere Lengths
There are certain genes within S. cerevisiae yeast that have been tested with genome-wide screens for deletion mutants that affect telomere length. Two such genes are MAK31 and VPS75. MAK31, generally categorized as a gene involved in protein modification, specifically with N-acetyltransferase, was found by Askree et al. to lengthen the yeast telomeres by 50-150 base pairs. VPS75, a gene that normally deals with vesicular traffic and vacuolar sorting proteins, was found in the same study to shorten yeast telomeres by 50-150 base pairs.
In cells with either a double or triple deletion of MAK31 or VPS75 in conjunction with EST2 and/or RAD52, growth curves should show shifts in when senescence occurs.
S. cerevisiae Strains
W303 diploid and BY4741a wildtype strains were generously donated by the Laboratory of Dr. David A. Sinclair, Harvard Medical School. The W303 diploid strain was sporulated and haploid colonies were then selected via replica plating onto selective media to select relevant haploid mutant strains. These strains were also used in our attempts by PCR to generate deletion cassettes. BY4741a strains were used to generate VPs75 and MAK31 deletion mutants by homologous recombination with deletion cassettes that we created using primers containing 5' ends having homology to the gene region and amplifying either a TRP1 or LEU2 cassette from plasmids.
Results
Daily Cell Density (cells/mL) For EST2, VPS75 and MAK31 Knockouts
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | Day 8 | Day 9 | Day 10 |
1296 | 61000000 | 21400000 | 85066666 | 58666666 | 116866666 | 574666667 | 78133333 | 106866666 | 83066666 | 86500000 |
VPS75 | 134500000 | 120000000 | 113833333 | 63800000 | 72433333 | 111500000 | 113700000 | 124100000 | 115000000 | 115400000 |
MAK31 | 131800000 | 118333333 | 117833333 | 145166666 | 118733333 | 120066666 | 117733333 | 125333333 | 116400000 | 120633333 |
The results for VPS75 and MAK31 show our predicted results. After the growth curve decreased on day 3 for VPS75, it increased again on day 4. The VPS75 growth curve leveled off after day 6. The MAK31 growth curve fluctuated a bit, but showed a general trend of decrease and then increase.
Daily Cell Density (cells/mL) For EST2 and EST2/RAD52 Knockouts
|
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
Day 6 |
W303A |
137600000 |
114500000 |
134050000 |
129750000 |
109050000 |
118450000 |
ΔEST2 (S21) |
115900000 |
16100000 |
13800000 |
55866666.67 |
118600000 |
102766666.7 |
ΔEST2 (S22) |
112300000 |
33433333.33 |
15133333.33 |
95033333.33 |
48900000 |
109500000 |
ΔRAD52/EST2 |
107500000 |
13266666.67 |
12366666.67 |
10933333.33 |
20433333.33 |
11233333.33 |
Future Directions
Given the forever ongoing nature of research, as well as the limited amount of time, our team was unable to fully complete certain tasks. With the opportunity to continue this project, we hope to proceed by next knocking out the SIR1 Gene or a similar gene with the intention of generating a strain that will be sterile (non-mating). In addition, we hope to control the activation and deletion of ADE2 Reporter Gene and EST2 respectively through the use of Galactose (Galactose Activated Cre Recombinase Switch).
References
-
Askree, S.H., Yehuda, T., Smolikov, S., Gurevich, R., Hawk, J., Coker, C., Krauskopf, A., Kupiec, M. and McEachern, M.J. (2004) A genome-wide screen for Saccharomyces cerevisiae deletion mutants that affect telomere length.
- Cohen, H., and Sinclair, D.A. (2001) Recombination-mediated lengthening of terminal repeats requires the Sgs1 DNA helicase. PNAS
- Lundblad, V., and Blackburn, E. H. (1993) An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 73:347-360.
- Lundblad, V., and Szostak, J.W. (1989) A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57: 633-643.
- N Nakayama, Y Kaziro, K Arai, and K Matsumoto. (1988)Role of STE genes in the mating factor signaling pathway mediated by GPA1 in Saccharomyces cerevisiae.Mol Cell Biol.8(9): 3777–3783.
- Botstein, D., Falcoa, S.C., Stewart, S.C.,Brennan, M., Scherer, S., Stinchcomb,D.T., Struhl, K., and Davis, R.W. (1979) Sterile host yeasts (SHY): A eukaryotic system of biological containment for recombinant DNA experiments
- Mackay V, Manney TR. (1974) Mutations affecting sexual conjugation and related processes in Saccharomyces cerevisiae. II. Genetic analysis of nonmating mutants. Genetics. Feb;76(2):273–288